Delivery Order SPE2DB22D2108-SPE2DB25FU3TY

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $8.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,340.71, is for the supply of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract is a firm fixed-price delivery order with a final completion date of March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $22,522.50, is for the delivery of the drug WEGOVY 1 MG/0.5 ML PEN 0.5ML. This is a firm fixed-price contract with a completion date of January 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corporation holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,661.55, is for the supply of the drug WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a firm fixed price and a period of performance through November 13, 2024. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of the drug WEGOVY 1 MG/0.5 ML PEN 0.5ML, with a ceiling value of $1,979.10 and a performance period ending on October 9, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen has been awarded numerous federal contracts by various defense...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,554.97, is for the delivery of the drug WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract is a firm-fixed-price, non-set-aside award with a completion date of July 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,780.28, is for the supply of the drug WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract is a firm fixed-price delivery order with an ultimate completion date of December 13, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,770.04, is for the delivery of the drug WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. It is a firm fixed-price contract with an ultimate completion date of October 22, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $14,689.06 firm fixed-price contract is for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has an ultimate completion date of August 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,571.17, is for the delivery of the drug product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. It is a firm-fixed price contract with a period of performance through November 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $21,385.91 firm-fixed-price contract is for the delivery of the prescription drug WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a period of performance through February 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB25FU3TY
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,410.14, is for the supply of the drug WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has a fixed-price structure and a completion date of March 11, 2025. Amerisourcebergen is the prime contractor, and there is no set-aside designation for this award. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/9/25, 9:53 AM